Pamidronate and uveitis.

Suppr

超能文献

作者信息

De S, Meyer P, Crisp A J

出版信息

Br J Rheumatol. 1995 May;34(5):479. doi: 10.1093/rheumatology/34.5.479.

DOI:10.1093/rheumatology/34.5.479

PMID:7788181

Abstract

摘要

相似文献

Pamidronate and uveitis.

Br J Rheumatol. 1995 May;34(5):479. doi: 10.1093/rheumatology/34.5.479.

Uveitis associated with pamidronate.

Aust N Z J Med. 1994 Jun;24(3):320. doi: 10.1111/j.1445-5994.1994.tb02186.x.

Paget's disease: ocular complications of disodium pamidronate treatment.

Br J Clin Pract. 1995 Sep-Oct;49(5):272-3.

Iritis following intravenous pamidronate.

Aust N Z J Med. 1996 Jun;26(3):414-5. doi: 10.1111/j.1445-5994.1996.tb01932.x.

Osteomalacia after pamidronate for Paget's disease.

Lancet. 1994 Apr 2;343(8901):855. doi: 10.1016/s0140-6736(94)92055-9.

Pamidronate in the treatment of Paget's disease.

Bone. 1999 May;24(5 Suppl):57S-58S. doi: 10.1016/s8756-3282(99)00060-5.

Pamidronate associated hallucinations.

Ann Rheum Dis. 1992 Jul;51(7):927-8. doi: 10.1136/ard.51.7.927-d.

Drug-induced optic neuritis and uveitis secondary to bisphosphonates.

N Z Med J. 2006 Mar 10;119(1230):U1888.

Pamidronate for Paget's disease of the bone.

Br J Hosp Med. 1995;53(3):66-8.

Pamidronate disodium and possible ocular adverse drug reactions.

Am J Ophthalmol. 1994 Aug 15;118(2):220-4. doi: 10.1016/s0002-9394(14)72902-2.

引用本文的文献

Drug-induced uveitis.

J Ophthalmic Inflamm Infect. 2013 Mar 25;3(1):43. doi: 10.1186/1869-5760-3-43.

Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Drugs. 2011 Apr 16;71(6):791-814. doi: 10.2165/11585470-000000000-00000.

Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Drugs Aging. 2006;23(7):535-58. doi: 10.2165/00002512-200623070-00001.

Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England.

Drug Saf. 2006;29(2):151-60. doi: 10.2165/00002018-200629020-00005.

Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England.

Osteoporos Int. 2005 Dec;16(12):1989-98. doi: 10.1007/s00198-005-1986-1. Epub 2005 Aug 31.

Drug-induced uveitis. Incidence, prevention and treatment.

Drug Saf. 1997 Sep;17(3):197-207. doi: 10.2165/00002018-199717030-00005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pamidronate and uveitis.

Br J Rheumatol. 1995 May;34(5):479. doi: 10.1093/rheumatology/34.5.479.

Uveitis associated with pamidronate.

Aust N Z J Med. 1994 Jun;24(3):320. doi: 10.1111/j.1445-5994.1994.tb02186.x.

Paget's disease: ocular complications of disodium pamidronate treatment.

Br J Clin Pract. 1995 Sep-Oct;49(5):272-3.

Iritis following intravenous pamidronate.

Aust N Z J Med. 1996 Jun;26(3):414-5. doi: 10.1111/j.1445-5994.1996.tb01932.x.

Osteomalacia after pamidronate for Paget's disease.

Lancet. 1994 Apr 2;343(8901):855. doi: 10.1016/s0140-6736(94)92055-9.

Pamidronate in the treatment of Paget's disease.

Bone. 1999 May;24(5 Suppl):57S-58S. doi: 10.1016/s8756-3282(99)00060-5.

Pamidronate associated hallucinations.

Ann Rheum Dis. 1992 Jul;51(7):927-8. doi: 10.1136/ard.51.7.927-d.

Drug-induced optic neuritis and uveitis secondary to bisphosphonates.

N Z Med J. 2006 Mar 10;119(1230):U1888.

Pamidronate for Paget's disease of the bone.

Br J Hosp Med. 1995;53(3):66-8.

Pamidronate disodium and possible ocular adverse drug reactions.

Am J Ophthalmol. 1994 Aug 15;118(2):220-4. doi: 10.1016/s0002-9394(14)72902-2.

引用本文的文献

Drug-induced uveitis.

J Ophthalmic Inflamm Infect. 2013 Mar 25;3(1):43. doi: 10.1186/1869-5760-3-43.

Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Drugs. 2011 Apr 16;71(6):791-814. doi: 10.2165/11585470-000000000-00000.

Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Drugs Aging. 2006;23(7):535-58. doi: 10.2165/00002512-200623070-00001.

Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England.

Drug Saf. 2006;29(2):151-60. doi: 10.2165/00002018-200629020-00005.

Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England.

Osteoporos Int. 2005 Dec;16(12):1989-98. doi: 10.1007/s00198-005-1986-1. Epub 2005 Aug 31.

Drug-induced uveitis. Incidence, prevention and treatment.

Drug Saf. 1997 Sep;17(3):197-207. doi: 10.2165/00002018-199717030-00005.